Michael Stickland
University of Alberta
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Stickland as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07140484 · Sotatercept in Pulmonary Arterial HypertensionUniversity of Alberta · recruiting · Pulmonary Artery Hypertension · principal investigator
- Ph2NCT06969573 · Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPDUniversity of Alberta · active not recruiting · COPD (Chronic Obstructive Pulmonary Disease) · principal investigator
- N/ANCT04966637 · Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative DataUniversity of Alberta · completed · Chronic Obstructive Pulmonary Disease (COPD · principal investigator
- Ph1/Ph2NCT04231760 · The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPDUniversity of Alberta · not yet recruiting · Chronic Obstructive Pulmonary Disease · principal investigator
- Ph1/Ph2NCT04181359 · The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.University of Alberta · withdrawn · Dyspnea · study director
- N/ANCT02398643 · Examine the Impact of Early Education on COPD ManagementUniversity of Alberta · completed · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
- N/ANCT01949727 · Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)University of Alberta · completed · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.Thromb Haemost · 1997102 citationsRCR 3.1
- 82 citationsRCR 3.3
- Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients.Diabet Med · 199172 citationsRCR 2.5
- 62 citationsRCR 2.6
- Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: A randomized-control cross-over trial.J Physiol · 202147 citationsRCR 4.0
- High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.Ann Am Thorac Soc · 201637 citationsRCR 1.8
- 34 citationsRCR 3.4
- Activation of the carotid chemoreflex secondary to muscle metaboreflex stimulation in men.Am J Physiol Regul Integr Comp Physiol · 201431 citationsRCR 1.5
- The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.J Physiol · 201830 citationsRCR 1.8
- Ventilatory responses to prolonged exercise with heavy load carriage.Eur J Appl Physiol · 201628 citationsRCR 2.2